StockTipsArenaBeta

BUY Biocon Ltd — Kunal Bothra

BUYBiocon Ltd
Biocon share price target & all analyst calls

byKunal BothraHorizon: NA (inferred Swing (≤2wk))22 Oct 2026via ET Now (Live)

Entry₹330.25Inferred
Target₹345
Total upside +4.47%
Stop loss₹320-3.10% risk
CMP₹330.31h ago
Active+0.02%+4.45%upside left 13d left
Follow Kunal Bothra for new calls(30% target hit, 275 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 149 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:26 pm IST
3 supporting3 opposing
Supports the BUY call (3)

RSI at 12 — oversold territory

Technicals · rsi·22 Oct · today

Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates

NewsCnbc-Tv18·14 Oct · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·19 Sept · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

MACD below its signal line — bearish momentum

Technicals · macd·22 Oct · today

Eris Lifesciences drops 3% after acquiring India formulation business of Biocon arm

NewsGoogle News·18 Oct · 4d ago

(opens in new tab)

1 advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Oct · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Kunal Bothra

Every call and its outcome